Panacea Venture, a Chinese GP founded by KPCB alumnus James Huang that specializes in early-stage healthcare investments, has closed its debut fund at approximately $180 million.
The vehicle, which launched 12 months ago with a target of $150 million, received commitments from family offices, endowments, sovereign wealth funds, pension funds, and fund-of-funds across Asia, the...
Fosun Group has agreed to invest RMB130 million ($18.4 million) in Pet Doctor, a Chinese one-stop pet services platform that supplies everything from software for pet hospitals to consultations for pet owners.
Japan Post Investment Corporation (JPIC) has backed a $33 million Series C round for Atonarp, a Tokyo-based molecular diagnostics systems developer that uses artificial intelligence (AI).
J.P. Gan (pictured), who spent 12 years with Qiming Venture Partners before striking out on his own earlier this year, has reached a first close of $163 million on his debut China fund.
Xyb2b.com, a B2B platform that helps Chinese e-commerce companies source products from overseas, has completed an extended Series B round of funding worth $100 million.